In addition to our observation that CerS6-derived C16:0 ceramides promote metabolic deterioration in obesity25,27, we have previously identified a role of skeletal muscle CerS1 and its product C18:0 ceramide in the development of obesity-associated insulin resistance25. This evidence concerns the gene CERS6 and obesity disorder.